Ameriprise Financial Inc. lifted its holdings in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 9.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 457,225 shares of the technology company’s stock after purchasing an additional 41,024 shares during the quarter. Ameriprise Financial Inc. owned 1.27% of Novanta worth $69,850,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of NOVT. Empowered Funds LLC bought a new position in Novanta in the fourth quarter valued at approximately $26,000. Johnson Financial Group Inc. lifted its position in Novanta by 482.1% in the 4th quarter. Johnson Financial Group Inc. now owns 326 shares of the technology company’s stock valued at $49,000 after acquiring an additional 270 shares in the last quarter. Huntington National Bank boosted its stake in Novanta by 53.6% in the 4th quarter. Huntington National Bank now owns 430 shares of the technology company’s stock worth $66,000 after purchasing an additional 150 shares during the period. SBI Securities Co. Ltd. bought a new position in Novanta during the 4th quarter worth about $97,000. Finally, Venturi Wealth Management LLC raised its stake in shares of Novanta by 6,500.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock valued at $111,000 after purchasing an additional 715 shares during the period. Institutional investors own 98.35% of the company’s stock.
Novanta Stock Performance
Shares of NASDAQ NOVT opened at $122.68 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. The stock has a 50 day moving average price of $123.66 and a 200 day moving average price of $146.02. The stock has a market capitalization of $4.41 billion, a PE ratio of 73.46 and a beta of 1.51. Novanta Inc. has a 52 week low of $98.76 and a 52 week high of $187.12.
Analysts Set New Price Targets
Separately, Robert W. Baird reduced their price objective on Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a research report on Monday, March 3rd.
Get Our Latest Analysis on Novanta
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Read More
- Five stocks we like better than Novanta
- How to Calculate Options Profits
- Google Is Betting Big on Nuclear Reactors—Should You?
- How to Calculate Return on Investment (ROI)
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.